Web Images Videos Maps News Shopping Gmail more »
Sign in
Go to Blog Search Home

  
  Advanced Blog Search
  Preferences
 Blog resultsResults 1 - 10 of about 99,154 for drug prescribing information. (0.26 seconds) 
Browse Top Stories
Published
Anytime

Subscribe:
Blogs Alerts Blogs Alerts
Atom | RSS
Sorted by relevance    Sort by date
 
Related Blogs:

Initial Data from CALGB-Led Study of Treatment with Continuous ...
18 Dec 2009
Renal impairment: Since lenalidomide is primarily excreted unchanged by the kidney, adjustments to the starting dose of REVLIMID® (lenalidomide) are recommended to provide appropriate drug exposure in patients with moderate or severe ... Please see full Prescribing Information, including Boxed WARNINGS, CONTRAINDICATIONS, PRECAUTIONS, and ADVERSE REACTIONS. About Multiple Myeloma. Multiple myeloma (also known as myeloma or plasma cell myeloma) is a cancer of the blood in ...
Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html
[ More results from Drugs.com - Clinical Trials ]

Oxycontin online prescriptions with no membership, buy Oxycontin ...
3 hours ago by pillsdrug  
does Oxycontin show up on drug test. legal Oxycontin. buy genuine Oxycontin online. buy real Oxycontin pay with mastercard. generic of Oxycontin. Oxycontin prescribing information. no prescription needed Oxycontin ...
Drupal Hub - Networking the Drupal World - http://www.drupalhub.org/
[ More results from Drupal Hub - Networking the Drupal World ]

FDA Approves Newly Revised Prescribing Information For AZILECT(R ...
15 Dec 2009
Teva Pharmaceutical Industries, Ltd. (NASDAQ: TEVA) announced the US Food and Drug Administration (FDA) approved the newly revised prescribing information for AZILECT® (rasagiline tablets) reducing medication and food restrictions...
Pharmainfo.net - Regulatory and Drug Approvals... - http://www.pharmainfo.net/taxonomy/term/2923/0

FDA Approves Newly Revised Prescribing Information for Azilect ...
14 Dec 2009
JERUSALEM--(BUSINESS WIRE)--Dec 14, 2009 - Teva Pharmaceutical Industries, Ltd. today announced the US Food and Drug Administration (FDA) approved the newly revised prescribing information for Azilect (rasagiline tablets) reducing ...
Drugs.com - New Drug Approvals - http://www.drugs.com/newdrugs.html

FDA Working to Revise Prescribing Information for Diabetes ...
4 Nov 2009 by ann@aafp.org  
The FDA is revising the prescribing information for the injectable diabetes medication exenatide and the oral diabetes drug sitagliptin phosphate following reports of renal problems associated with exenatide use, as well as reports ...
AAFP News Now - http://www.aafp.org/online/en/home/publications/news/news-now.html - References
[ More results from AAFP News Now ]

Test - why cant i post - SoberRecovery : Alcoholism Drug Addiction ...
14 hours ago by TakingControl  
SoberRecovery : Alcoholism Drug Addiction Help and Information > Special-Interest Groups > Women In Recovery. Test - why cant i post ... It started with Vicodin, then to Oxycodone, then it got to a point where I was needing more of the medication to treat the daily pain & after about 6 months of having my OBGYN prescribing me these meds she sent me to a local pain clinic. I visited the pain clinic for the first time on my 19th birthday - I was so hopeful & excited - after ...
SoberRecovery : Alcoholism Drug Addiction... - http://www.soberrecovery.com/forums/

FDA Approves Newly Revised Prescribing Information for AZILECT ...
14 Dec 2009 by Business Wire  
JERUSALEM–(BUSINESS WIRE)– Teva Pharmaceutical Industries, Ltd. (NASDAQ: TEVA) today announced the U.S. Food and Drug Administration (FDA) approved the newly revised prescribing information for AZILECT® (rasagiline tablets) reducing ...
Your Story - http://www.your-story.org/
[ More results from Your Story ]

Important Safety Information About Lexiva - on RxList
7 Dec 2009
GSK has added myocardial infarction and hypercholesterolemia to the Side Effects and Drug Interactions section of the LEXIVA Tablets and Oral Suspension prescribing information. Elevations in triglyceride levels are already described in ...
RxList - News and Features - http://www.rxlist.com/script/main/hp.asp
[ More results from RxList - News and Features ]

JediTheOne: Dangerous Drugs II...it continues!
7 hours ago by DarkStar888  
Dr. Steinman has an active interest in pharmaceutical marketing practices and subtle ways that the industry may influence the prescribing behaviors of physicians. Depression erectile dysfunction anxiety bipolar medication acid relfux ... Here, at Drug.com, this site lists most drugs know to man. This is a fairly neutral view, in other words, just stating information based of what know about these persription medications. This site gives comprehensive information on each ...
JediTheOne - http://jeditheone.blogspot.com/

Thallion Discontinues Phase II Glioblastoma Multiforme Trial After ...
18 Dec 2009
Endo, Novartis and FDA notified healthcare professionals of revisions to the Hepatic Effects section of the prescribing information to add new warnings and ... More... Get Updates by Email. Email me: Drugs.com monthly newsletter ...
Drugs.com - Pharma News - http://www.drugs.com/news.html
[ More results from Drugs.com - Pharma News ]

Stay up to date on these results:




 
  

Google Home - About Google Blog Search Beta - Information for Blog Authors

©2009 Google